J. Goldman & Co’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Hold |
0
| – | – | – | 377 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 376 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 254 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 268 |
|
|
2023
Q2 | – | Sell |
-387,654
| Closed | -$4.3M | – | 282 |
|
|
2023
Q1 | $4.3M | Buy |
387,654
+162,743
| +72% | +$1.8M | 0.17% | 108 |
|
|
2022
Q4 | $2.75M | Buy |
+224,911
| New | +$2.75M | 0.13% | 119 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 272 |
|
|
2022
Q1 | – | Sell |
-170,946
| Closed | -$1.97M | – | 272 |
|
|
2021
Q4 | $1.97M | Buy |
170,946
+129,511
| +313% | +$1.5M | 0.11% | 151 |
|
|
2021
Q3 | $396K | Buy |
+41,435
| New | +$396K | 0.02% | 220 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 208 |
|
|
2019
Q4 | – | Sell |
-161,946
| Closed | -$1.3M | – | 201 |
|
|
2019
Q3 | $1.3M | Buy |
+161,946
| New | +$1.3M | 0.1% | 104 |
|
|
2018
Q2 | – | Sell |
-81,618
| Closed | -$1.23M | – | 258 |
|
|
2018
Q1 | $1.23M | Sell |
81,618
-142,504
| -64% | -$2.14M | 0.05% | 163 |
|
|
2017
Q4 | $3.23M | Buy |
224,122
+20,622
| +10% | +$297K | 0.17% | 90 |
|
|
2017
Q3 | $3.07M | Buy |
+203,500
| New | +$3.07M | 0.15% | 95 |
|
|
2016
Q4 | – | Sell |
-88,800
| Closed | -$657K | – | 225 |
|
|
2016
Q3 | $657K | Buy |
+88,800
| New | +$657K | 0.04% | 161 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 191 |
|
|
2015
Q1 | – | Sell |
-400,000
| Closed | -$3.33M | – | 186 |
|
|
2014
Q4 | $3.33M | Buy |
+400,000
| New | +$3.33M | 0.39% | 58 |
|